Results 221 to 230 of about 817,567 (359)

Factors Associated With Frequent Needle Exchange Program Attendance in Injection Drug Users in Vancouver, Canada

, 1998
Chris Archibald, Marianna Ofner, Steffanie A. Strathdee, David M. Patrick, Donald Sutherland, Michael L. Rekart, Martin T. Schechter, Michael V. O’Shaughnessy   +7 more
openalex   +1 more source

Multi‐omic profiling of squamous cell lung cancer identifies metabolites and related genes associated with squamous cell carcinoma

Molecular Oncology, EarlyView.
Using multi‐omic characterization, we aimed to identify key regulators specific to squamous cell lung carcinoma (SqCC). SqCC‐specific differentially expressed genes were integrated with metabolics data. High expression of the creatine transporter SLC6A8, along with elevated creatine levels, appeared to be a distinct metabolic feature of SqCC.
Johan Staaf, Daniel Ehinger, Hans Brunnström, Mats Jönsson, Frida Rosengren, Marija Kotevska, Anna Karlsson, Mattias Aine, Christian Frezza, Maria Planck, Elsa Arbajian   +10 more
wiley   +1 more source

Tuberculosis screening and compliance with return for skin test reading among active drug users.

, 1998
C. Kevin Malotte, Fen Rhodes, Kiera Mais
openalex   +1 more source

Opening remarks, Human Rights Watch/Open Society Institute Panel Discussion on the Human Rights of Drug Users in an era of HIV/AIDS, 1 April 2004 [PDF]

, 2004
Hunt, PH
core  

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

Molecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Philipp Franz Linden, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Matthias Stechele, Marianna Alunni‐Fabbroni   +14 more
wiley   +1 more source

Higher prevalence of pulmonary tuberculosis revealed by Xpert MTB/RIF ultra among drug users in Kinshasa, Democratic Republic of Congo. [PDF]

BMC Infect Dis
Nkisi GB, Yobi DM, Zono BB, Kabututu PZ, Mikobi TM, Bisuta SF.   +5 more
europepmc   +1 more source

Evaluation and Comparison of Serum Vitamin D Levels between Injection Drug Users with and without Chronic Hepatitis C Infection in Hamadan-Iran. [PDF]

Maedica (Bucur), 2023
Eini P, Hatami M, Eini P, Poorolajal J.
europepmc   +1 more source

Impaired cognitive performance in drug free users of recreational ecstasy (MDMA) [PDF]

, 2000
Euphrosyne Gouzoulis‐Mayfrank
openalex   +1 more source

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

Molecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu, Jianlei Zhao, Aaban Asfar Azmi, Avanti Gupte, Jenna Thibodeau, Shuang Liu, Jinli Yang, Guan Wang, Holly Edwards, Lisa A. Polin, Juiwanna Kushner, Sijana H. Dzinic, Kathryn White, Julie Boerner, Maik Hüttemann, Jay Yang, Yue Wang, Jeffrey W. Taub, Yubin Ge   +18 more
wiley   +1 more source

A comprehensive approach to healthcare for drug users in Catalonian prisons. [PDF]

Rev Esp Sanid Penit
Gasulla Suriol L, de Gispert Arnó T.
europepmc   +1 more source